CO2 Promoting Polymorphic Transformation of Clarithromycin: Polymorph Characterization, Pathway Design, and Mechanism Study

Carbon dioxide (CO2) has a wide range of uses such as food additives and raw materials for synthetic chemicals, while its application in the solid-state transformation of pharmaceutical crystals is rare. In this work, we report a case of using 1 atm CO2 as an accelerator to promote the polymorphic transformation of clarithromycin (CLA). Initially, crystal structures of Form 0′ and three solvates were successfully determined by single crystal X-ray diffraction (SCXRD) analysis for the first time and found to be isomorphous. Powder X-ray diffraction (PXRD) and thermal analysis indicated that the solvate desolvates and transforms into the structurally similar non-solvated Form 0′ at room temperature to ~50 °C. Form 0′ and Form II are monotropically related polymorphs with Form II being the most stable. Subsequently, the effect of CO2 on the transformation of CLA solvates to Form II was studied. The results show that CO2 can significantly facilitate the transformation of Form 0′ to Form II, despite no significant effect on the desolvation process. Finally, the molecular mechanism of CO2 promoting the polymorphic transformation was revealed by the combination of the measurement of adsorption capacity, theoretical calculations as well as crystal structure analysis. Based on the above results, a new pathway of preparing CLA Form II was designed: transform CLA solvates into Form 0′ in 1 atm air at 50 °C followed by the transformation of Form 0′ to Form II in 1 atm CO2 at 50 °C. This work provides a new idea for promoting the phase transformation of pharmaceutical crystals as well as a new scenario for the utilization of CO2.